rhenium has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R | 1 |
Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Rattat, D; Reske, SN; Seitz, U | 1 |
2 other study(ies) available for rhenium and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation | 2003 |
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liver; Lung; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Rate; Tissue Distribution; Transplantation Conditioning | 2002 |